Baldeviano et al found that IL‐17A is able to stimulate the growth of dilated cardiomyopathy, and suppression of IL‐17A reduces the myocarditis‐induced cardiac fibrosis and also alleviates ventricular function.25 Here, IL17A is linked to myocarditis.